Fundz

Tubulis Appoints Charles Fuchs as Chief Medical Officer

PRIVATEJan 08, 2026

Position

Chief Medical Officer

Company

Tubulis

Charles Fuchs
MunichBiotechnologyHealth Care

Description

Tubulis announced the appointment of Dr. Charles Fuchs as Chief Medical Officer. Dr

Quick answer

Tubulis Appoints Charles Fuchs as Chief Medical Officer (January 8, 2026). Tubulis is based in Munich, Bavaria, Germany.

Who is the new Chief Medical Officer at Tubulis?
Tubulis named Charles Fuchs Chief Medical Officer, announced January 8, 2026.
What did Tubulis announce on January 8, 2026?
Tubulis announced the appointment of Dr. Charles Fuchs as Chief Medical Officer.
What does Tubulis do?
Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology.
Where is Tubulis based?
Tubulis is based in Munich, Bavaria, Germany.
Which similar companies made leadership changes around the same time?
Enara Bio (January 8, 2026), Nature's Toolbox (January 8, 2026), Arkstone (January 8, 2026) and Psilera (January 8, 2026) also announced leadership changes within 45 days of Tubulis.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Tubulis, and when

A new leader at Tubulis brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Tubulis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Tubulis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Tubulis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Tubulis

Location

Munich, Bavaria, Germany

About

Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Our goal is to expand the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. We will advance a range of conjugates, unlimited by indication, using our own discovery capabilities and by solving development challenges for partners with both antibody and chemical assets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Tubulis changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Dominik
Likely contact at this company
••••••••@••••••••

See Dominik's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Tubulis's next move

Learn about Strategic plan

Tubulis changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.